Both drugs, however, significantly reduced myocardial CCL2 concentration 3 days after MI (Figure 3B), whereas only anti–IL-6-Ab increased C-X-C motif ligand 1 (CXCL1) concentration 4 h after MI (Figure 3C). The gene discussed is IL6; the disease is myocardial infarction.